Material and methods
Altogether 103 adult patients with persistent bacteriuria ( 105 CFU/ml in at least two consecutive urinary specimens) were studied. They have been grouped according to the following criteria.
GROUP 1
This group comprised 58 subjects with chronic obstructive pyelonephritis. The diagnosis was based Mengoli, Arosio, Bonato, Spiazzi, Pancera, Montesi, Lechi, anid Scuro on microbiological grounds (the aforementioned persistent significant bacteriuria) and on both clinical and pyelographic evidence of long-standing upper urinary tract obstruction. Patients not fulfilling these criteria were discarded from the study. Therefore, so-called non-obstructive ('primitive') pyelonephritis was not taken into account. On these grounds, renal biopsy appeared unnecessary to confirm the diagnosis and was never performed.
To assess the influence of the extent of renal parenchymal involvement in determining the outcome of the test, we divided this group into two subgroups according to the absence (subgroup la, 27 subjects) and the presence (subgroup lb, 31 subjects) of chronic renal insufficiency. This was demonstrated by a persistently elevated serum creatinine concentration (> 1-3 mg/dl, normal values for our laboratory = 05-1 2 mg/dl). GROUP 2 This group comprised 45 subjects with a lower UTI; they had both a normal renal function and a normal pyelographic appearance of the upper urinary tract. Of these patients, 31 had an asymptomatic bacteriuria (subgroup 2a), whereas the remaining 14 patients had a long-standing symptomatic lower UTI due to either prostatic hypertrophy or anatomical bladder abnormalities (mostly neoplasms, diverticula, and calculi) (subgroup 2b).
ACB were sought by means of the direct immunofluorescence technique (Fig. 1) previous incubation with a non-fluorescent antihuman immunoglobulin serum from rabbit (Coombs' serum). The specificity of the secretary component detection was checked in two ways: (1) by performing the whole indirect immunofluorescence technique on the infecting bacterial strain as isolated on a solid culture medium; and (2) by incubating the urinary sediment bacteria with a fluorescent antirabbit immunoglobulin only. The criteria used by Jones15 have been employed for defining a urine specimen positive for ACB. The differences between groups 1 and 2, between subgroups la and lb, and between subgroups 2a and 2b have been evaluated statistically by means of the x2 test with Yates' correction.
Results
Forty-nine of the 58 subjects in group 1 (84-5%) and 5 of the 45 subjects in group 2 (111 Y%) were positive. This difference was statistically significant (X2 = 51-79; P < 0-001).
Twenty-one positive cases were recorded in subgroup la (77-8 %), whereas 28 positive cases were observed in subgroup lb (90-3y%) (Table 1) . This difference was not statistically significant. (Table 2 ). In the 13 subjects negative for anti-human immuno- The latter mechanism could explain the existence of a few 'false-positive' cases in the group with lower UTI; on the other hand, the higher frequency of the positive finding of ACB in the group with upper UTI might be explained by a stronger antigenic stimulation in the latter condition.
If we accept the second hypothesis, the presence of specific antibodies in the fluid phase of urine is a preLminary condition for the immune complex formation (ACB, in this case). Whereas some authors failed to detect fluid phase antibodies in the urine of patients with pyelonephritis, Hanson23 was able to find them in a large proportion of upper UTI and, less frequently, in lower UTI.
To explain the presence of antibodies in urine, a passive leak from serum cannot at present be ruled out in every case. However, the coexistence of specific antibodies in serum and urine in pyelonephritis has been found to be very inconsistent. 4 In summary, we favour the local secretory antibody hypothesis. 
